admin – Page 4664 – Get News Story

Airway Management Devices Market is projected to register an impressive CAGR, Revenue, and Prominent Players by 2028

“The airway management devices industry is expected to experience significant growth over the next few years. This is due to the increasing demand for advanced medical devices that help to manage a patient’s airway during medical procedures.”

Browse 235 market data Tables and 43 Figures spread through 295 Pages and in-depth TOC on “Airway Management Devices Market by type (Endotracheal tubes, Tracheostomy tube, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Resuscitators), Application (Anesthesia, Emergency medicine), End user (Hospitals, Home care settings)- Global Forecast to 2028

Airway Management Devices Market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.4 billion by 2028, growing at a CAGR of 5.6% from 2022 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by increasing prevalence of respiratory tract infections and chronic respiratory diseases. Moreover, increasing number of emergency care admission and favourable reimbursement coverage across emerging countries supporting the growth of airway management devices market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116806061

Laryngoscopes segment is expected to account for the second largest share in 2022.

Laryngoscopy is a medical procedure that provides a full view of the vocal folds and the glottis using a laryngoscope. Increasing demand of laryngoscopes are attributed to the rising burden of respiratory complications due to increasing pollution and growing need for intubation and chronic respiratory disease prevalence is expected to drive the airway management devices market.

The anesthesia segment held the largest market share in the airway management devices market by application

By application, the anesthesia segment accounted for the largest share in 2022. Airway management devices are widely used in anesthesia for maintaining unobstructed breathing during and after the surgical procedure. Increasing number in surgical procedures and demand for maintaining a safe breathing passage to lower the risk of anesthesia-related complications during surgery is driving the demand for airway management devices in the anesthesia segment.

The pediatric patient segment is expected to grow at the highest rate during the forecast period

The pediatric/neonatal patients’ segment is expected to show rapid growth in the patient age segment during the forecast period. Factors attributing to the growth of the segment is due to the rising number of pre-term births and the rising healthcare expenditure and the improving healthcare infrastructure in countries are contributing to the rapidly increasing demand for infant/neonatal airway management devices.

Hospitals dominates the global airway management devices market during the forecast period

Based on end-user the hospital segment accounted for the largest market share during the forecast period. The large share of this segment can be attributed to the increasing number of hospitals and economic & infrastructural development, especially in developing countries. Moreover, the increasing surgical procedures performed across emerging rooms where airway management devices are used also supports growth in the hospitals segment.

Asia Pacific is expected to account for the highest CAGR in the airway management devices market

The Asia Pacific airway management devices market is expected to grow at the highest CAGR during the forecast period. Asia Pacific is driven by rising number of geriatric populations, increasing demand for critical care units and the low infrastructure and treatment costs and the presence of highly educated physicians have driven medical tourists to APAC countries, particularly to Malaysia, India, and China.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=116806061

Airway Management Devices Market Dynamics:

Drivers:

Increasing prevalence of chronic respiratory diseases
Growing demand for emergency and intensive care
Growing incidence of pre-term births globally
Government support for improving emergency care infrastructure

Restraints:

Lack of reimbursement policies across developing countries

Opportunities:

Growing demand for single-use airway management devices
Increased growth potential in emerging countries

Challenges:

Harmful effects of airway management devices on neonatal patients
Dearth of skilled professionals for airway management procedures
Increasing pricing pressure on key market players

Key Market Players:

The airway management devices market is dominated by players such Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=116806061

Airway Management Devices Market Advantages:

Provides a detailed analysis of the current and emerging Airway Management Devices market trends and dynamics.
Offers an in-depth analysis of the market size in terms of volume and value.
In-depth analysis of the key segments of the Airway Management Devices market.
Comprehensive analysis of the factors that drive and restrain the growth of the market.
Comprehensive analysis of the regional markets for Airway Management Devices.
Comprehensive analysis of the competitive landscape and detailed profiles of the major players in the market.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/airway-management-device-market-116806061.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Airway Management Devices Market is projected to register an impressive CAGR, Revenue, and Prominent Players by 2028

Transplant Diagnostics Industry worth $6.8 billion by 2028, with a CAGR of 7.4%

“The transplant diagnostics industry is likely to see some major advances in the near future. There are a number of new technologies and treatments being developed that will revolutionize the way transplant diagnostics are done.”

Browse 168 market data Tables and 44 Figures spread through 260 Pages and in-depth TOC on “Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product(Instrument, Reagent, Software), Application(HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User, & Region – Global Forecasts to 2028

Transplant Diagnostics Market in terms of revenue was estimated to be worth $4.4 billion in 2022 and is poised to reach $6.8 billion by 2028, growing at a CAGR of 7.4% from 2022 to 2028 according to a new report by MarketsandMarkets™. Organ transplants have gradually improved over the past 20 years and typically produce excellent results in children and young adults. However, the proportion of elderly transplant patients with comorbidities is increasing, posing a greater challenge. When compared to dialysis, renal transplants increase patient survival, and patients with liver, heart, or lung diseases that are incurable must receive life-saving transplants. The activity of solid organ transplant programmes has been steadily increasing, but it still falls short of global needs and varies greatly between nations. Transplanting solid organs is crucial for advanced and established medical systems.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061

Molecular assay technologies segment to register a significant growth rate over the forecast period of 2022-2028

Based on Technology, molecular assay technologies are segmented to witness the highest growth during the forecast period. Molecular assay technologies are segmented into PCR-Based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further segmented into Real-time PCR, Sequence-specific primer, Sequence-specific Oligonucleotide and other PCR-based molecular assays.

Sequence-specific Oligonucleotide is growing at the highest CAGR of 9.5%.

The Reagents & Consumables holds the largest share in the Product and Service segment of the Transplant diagnostic market.

The reagents and consumables is projected to reach USD 5,131.0 million from USD USD 3,265.2 million in 2022 with the CAGR of 7.8%.

Based on End users, the transplant diagnostic market is segmented into Hospitals and Diagnostic centers, Research & Academic Institutes and Independent reference laboratories. The Independent reference laboratories segment accounted for the largest share of the transplant diagnostic market. The growing number of organ transplant procedures and growing number of diagnostic labs across emerging countries are helping the independent diagnostic centers to hold the largest share.

North America to register major growth in the market during the forecast period

North America transplant diagnostic market is anticipated to register the highest growth over the forecast period of 2022 to 2028. North America accounted for the largest share of 45.5% of the transplant diagnostic market in 2022. This market is projected to reach USD 3.1 billion by 2028 from USD 2.0 billion in 2022, at a CAGR of 7.6% during the forecast period. North America holds 45.5% share of the total antimicrobial susceptibility testing market. The large share of North America can be attributed due to the growth in the geriatric population and the increase in infectious diseases., Asia-Pacific is expected to experience significant development.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=2531061

Transplant Diagnostics Market Dynamics:

Drivers:

Increasing number of transplant procedures
Technological advancements in transplant diagnostic procedures
Increasing public-private funding for target research activities
Rising prevalence of infectious diseases

Restraints:

High procedural cost of NGS- and PCR-based diagnostic assays
Limited reimbursement for target procedures

Opportunities:

Rising adoption of cross-matching and chimerism testing during pre- & post-transplantation
Growing public awareness about organ donation and transplantation

Challenges:

Significant gap between number of organ donors and organs required annually
Procedural and technical limitations associated with donor-recipient screening

Key Market Players:

As of 2022, prominent players are Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.F-Hoffman-LA-Roche, and Thermo fisher Scientific.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=2531061

Transplant Diagnostics Market Advantages:

Transplant diagnostics allow for improved accuracy in the diagnosis and treatment of organ transplant recipients.
More accurate diagnostic tests can lead to earlier detection and treatment of organ transplant complications, reducing the risk of organ rejection and other transplant-related complications.
Improved accuracy can reduce health care costs by reducing the number of unnecessary treatments and tests.
Transplant diagnostics can also help to identify the most suitable donor organs for transplantation, reducing the risk of organ rejection and improving the success rate of transplants.
Transplant diagnostics can also help to improve the quality of life for transplant recipients by providing more accurate and timely diagnosis and treatment.

Transplant Diagnostics Market – Report Highlights:

The study consists of the average selling price (ASP) analysis for different products in the Transplant Diagnostic market.
The research study comprises the patent analysis of technologies/solutions used in the Transplant Diagnostic market
The new market study consists of the trends/disruptions impacting customers’ businesses.
The new market study consists of information on key conferences and events in 2022–2028.
The new market study consists of the region-wise regulatory landscape.
The new market study provides details of the strategies of the top 5 players operating in the market.
The competitive landscape chapter has been updated with the market evaluation matrix. The competitive landscape also includes the market share analysis of major global players (as of 2021), updated competitive leadership mapping, and competitive situations and trends.
The new market study comprises 25 players. These companies have emerged as key market players in recent years due to their products and various strategic investments undertaken in the transplant diagnostic market.
Updated financial information/product portfolio of players: The new edition of the report provides updated financial information in the context of the medical aesthetic market from January 2020 to July 2022 (depending on availability) for each listed company in graphical representation.
Updated market developments of profiled players: The current report includes the market developments from January 2022 to July 2022.

During the production cycle of the report, in-depth interviews were conducted with various primary respondents, which include key opinion leaders, subject matter experts, directors, and C-level executives of selected particle counters vendors to obtain and verify critical qualitative and quantitative information. This primary data was collected mainly through questionnaires, mails, and telephonic interviews.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Transplant Diagnostics Industry worth $6.8 billion by 2028, with a CAGR of 7.4%

More Electric Aircraft Market worth $8.01 Billion by 2029, at a CAGR of 7.6%

“More Electric Aircraft Market”

The global More Electric Aircraft Market in terms of revenue is estimated to be worth $5.56 billion in 2024 and is poised to reach $8.01 billion by 2029, growing at a CAGR of 7.6% during the forecast period.

The report “More Electric Aircraft Market by System (Propulsion, Airframe), Component (Power Source, Actuators, Electric Pump, Power Electronics, Generator, Valves), Platform (Narrow Body, Wide Body, Regional Jet, Fighter Jet), Application, End Use – Forecast to 2029″ more electric aircraft market is projected to grow from USD 5.56 billion in 2024 and reach USD 8.01 billion by 2029, at a CAGR of 7.6% during the forecast period.

The More Electric Aircraft (MEA) market is revolutionizing aviation by integrating electric systems across various aircraft functions, significantly enhancing efficiency and reducing environmental impact. Its applications range from highly accurate and low-maintenance electric flight control systems, to the increased safety and reliability offered by electric-driven landing gear, to optimal energy usage in heating and cooling provided by electric power for environmental control systems. Through Electric Taxiing Systems (ETS), aircraft can taxi without engines, hence cutting fuel usage and emissions associated with ground operations. High-voltage power distribution systems enable efficient power delivery to subsystems and improve operational reliability. In addition, further developments in battery technology, such as solid-state and lithium-sulfur batteries, are required for energy storage in electric systems. Electric propulsion is still in its development stage, but it can significantly reduce emissions for short- to medium-haul flights.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138024896

Browse 338 market data Tables and 73 Figures spread through 288 Pages and in-depth TOC on “More Electric Aircraft Market – Forecast to 2029”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/more-electric-aircraft-market-138024896.html

Based on platform, Fixed-wing segment is estimated to account for the largest market share in More Electric Aircraft market from 2024 to 2029.

The more electric aircraft market is further segmented into fixed-wing and rotary-wing aircraft based on platform. Fixed-wing aircraft will form the majority share of More Electric Aircraft as they will be used highly in all commercial, regional, and cargo aviation sectors. Fixed wing aircraft serve assorted routes and distances, hence are a much more ideal candidate for innovations related to MEA as such can facilitate fuel efficiency, and further reduce the emission.

Based on End User, Military segment is estimated to grow at the fastest rate in More Electric Aircraft market from 2024 to 2029.

The market is classified into civil and military, based on end-user. The military segment is anticipated to grow at the fastest rate in the More Electric Aircraft (MEA) market due to the major benefits that is acquired from replacing pneumatic systems by electric in aircraft. Electrical systems increase reliability and lower maintenance frequency, which could prove very critical in the military environment where aircraft might get exposed to extreme climatic conditions. For example, the U.S. Flight controls surfaces of the F-35 Lightning II from Air Force are electrically operated and not hydraulic systems for such applications, hence the aircraft is very light, responsive, and efficient in operations.

The European market is projected to contribute the most significant share from 2024 to 2029 in the More Electric Aircraft market

The more electric aircraft regional analysis has been studied over North America, Europe, Asia Pacific, Middle East & Africa and Latin America. The growth in aircraft deliveries is expected to propel the MEA market in Europe, with demand for new, fuel-efficient, and environmentally friendly aircraft on the rise. European airlines are expanding and updating their fleets to meet rising passenger travel demand and to align with stringent EU emissions regulations. This requirement necessitates more advanced MEA technologies in aircraft wherein electric systems replace the hydraulic and pneumatic systems that otherwise would be in place. This, therefore, makes the system lighter, efficient, and has lower operating costs. For the companies such as Airbus that are headquartered in Europe, the thrust has now been to design and manufacture new aircraft equipped with the MEA innovations, which include electric actuation systems, electric environmental control, and power-by-wire technology. These have made tremendous differences in more fuel-efficient solutions for airlines, lowering their maintenance needs and generally improving performance. In the event of net-zero emission aspirations across Europe being put into place by 2050, airlines would embrace these new aircraft because they meet their sustainable standards.

The key market players in the more electric aircraft market are S.A ( France), Honeywell International Inc. (US), RTX (US), General Electric (US), Parker Hannifin Corporation (US), Bae Systems plc (UK), Bomardier Inc. (Canada), Embraer S.A (Brazil), Liebherr (Switzerland), Ametek Inc. (US), Astronics Corporation (US), Moog inc. (US), Rolls-Royce Plc (UK), Amphenol Corporation (US), Eaton (Ireland).

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Delray Beach
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/more-electric-aircraft-market-138024896.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: More Electric Aircraft Market worth $8.01 Billion by 2029, at a CAGR of 7.6%

Future Electronics Spreads Holiday Cheer with Festive Lunch and Giving Campaign

Future Electronics recently celebrated the holiday season with a festive lunch, exciting prizes and a giving campaign. Employees came together to donate food and winter essentials, spreading cheer and making a difference in the community.

Montreal, Canada – December 10, 2024 – Future Electronics, a global leader in electronics components distribution, recently celebrated the holidays with its annual holiday lunch. On Friday, December 6, 2024, Future Electronics employees gathered in the cafeteria to enjoy a warm and delicious meal.

The event was more than just a celebration; it was a testament to Future Electronics’ commitment to giving back to the community. Attendees donated non-perishable food items and new hats, mittens, socks and scarves, earning prize draw tickets for each item contributed.

The generosity of employees was rewarded with chances to win exciting prizes, including gift cards, electronics and more. The donated items were then placed around Future Electronics’ two “Community Trees.”

The prize draw, held around 1:00 pm, added excitement to the day as participants celebrated both their contributions and the joy of the season.

Future Electronics remains committed to fostering a supportive workplace and a strong sense of community. The holiday lunch and giving campaign showcased the company’s dedication to teamwork, integrity, and making a meaningful impact in the lives of both their employees, and the surrounding community.

For more information about Future Electronics, visit: https://www.futureelectronics.com/about-future

About Future Electronics:

Founded in 1968, Future Electronics is a global leader in the electronic components industry. Future Electronics’ award-winning customer service, global supply chain programs and industry-leading engineering design services have made the company a strategic partner of choice.

Headquartered in Montreal, Canada, Future Electronics operates in 159 offices across 44 countries with over 5,000 employees. Its worldwide presence powers the company’s outstanding service and efficient, comprehensive global supply chain solutions. Future Electronics is globally integrated and supported by one IT infrastructure which provides real-time inventory availability and enables fully integrated operations, sales and marketing services worldwide. In 2024, Future became a WT Microelectronics company, now dual-headquartered in both Montreal, Canada and Taipei City, Taiwan.

Future Electronics’ mission is always to Delight the Customer®. For more information visit www.FutureElectronics.com.

Media Contact
Company Name: Future Electronics
Contact Person: Jamie Singerman
Email: Send Email
Phone: 514-694-7710
Address:237 Hymus Boulevard
City: Pointe Claire
State: Quebec
Country: Canada
Website: https://www.futureelectronics.com/

Liberty Roofing Pro’s Released “Choosing the Right Franklin Roofing Company,” – A Guide for Homeowners in Franklin, PA

Liberty Roofing Pro’s, a trusted name in local roofing, has announced the launch of its new guide, “Choosing the Right Franklin Roofing Company.” With this new guide,homeowners now have a clear roadmap for selecting a roofing contractor they can count on, making choosing the right roofing company in Franklin, PA, simpler and faster.

This user-friendly guide, available on the Liberty Roofing Pro’s website, breaks down what to look for in a roofing company — from experience and certifications to warranties and pricing transparency. It’s designed to give homeowners the confidence they need to make smart choices for one of the biggest investments in their home.

“We know picking a roofing company can feel overwhelming, ” said Abner Miller, Owner of Liberty Roofing Pro’s. “That’s why we created this guide. It’s like having a friend in your corner who’s been through it before. We want homeowners to know what to ask, what to look for, and how to avoid the most common mistakes.”

To spot a trusted roofer in Franklin, PA, there are a few things homeowners need to check before signing a contract. In its guide, Liberty Roofing Pro’s recommends focusing on these key areas:

● Experience and Certifications: Does the company have proper licenses and certifications? Look for GAF Master Elite contractors or Owens Corning Preferred Contractors. These credentials show that a roofer has been vetted for skill, training, and professionalism.

● Reputation and Reviews: Do they have good online reviews? Happy customers leave positive feedback, and reputable companies are happy to share customer testimonials and references.

● Transparent Pricing and Estimates: Are they giving homeowners a clear, itemized estimate? Avoid vague quotes or “ballpark” numbers. You deserve to know exactly what you’re paying for.

● Warranties and Guarantees: Are their products and services backed by strong warranties? The best roofing companies offer both manufacturer warranties (on materials) and workmanship warranties (on labor).

● Local Presence and Knowledge: Are they part of the local community? Local roofing companies understand the unique weather and environmental factors that can affect a roof.

These tips are part of the free guide now available from Liberty Roofing Pro’s. Following this advice can help homeowners avoid costly mistakes and choose a roofing contractor they can trust.

“The number one mistake we see is people rushing to pick a contractor after storm damage,” said Abner. “It’s understandable — you’re stressed and just want it fixed fast. But slowing down just a bit to check credentials and reviews can save you a lot of money and headaches later.”

Why Franklin, PA Homeowners Trust Liberty Roofing Pro’s

Liberty Roofing Pro’s has deep experience working in Franklin, PA, and knows what roofs in the area need to stand up to the elements. This Franklin roofing company has built its reputation on honesty, quality work, and customer-first service.

Some of the key advantages of Liberty Roofing Pro’s include:

● Local Knowledge: Liberty Roofing Pro’s has been working on roofs in Franklin, PA, for years. They understand the local weather, from harsh winters to summer storms, and they build roofs to withstand it all.

● Comprehensive Roofing Services: Whether it’s a small roof repair after a storm or a full roof replacement, Liberty Roofing Pro’s offers complete roofing solutions. They also handle inspections and preventative maintenance to keep roofs in top shape year-round.

● Customer-Centered Approach: Their team is known for being honest, transparent, and easy to work with. If something isn’t right, they make it right. It’s not just about finishing the job — it’s about doing it right the first time.

● Expert Workmanship: Their roofing crews are trained, certified, and experienced. No shortcuts, no cheap materials, just skilled roofing professionals using high-quality products.

● Commitment to Communication: From start to finish, homeowners are kept in the loop. Liberty Roofing Pro’s makes sure you know what’s happening at every step of the project, so there are no surprises.

“We treat every customer like a neighbor, “ said Abner. “That means clear communication, honest prices, and roofing work that stands the test of time. When you work with Liberty Roofing Pro’s, you’re working with a company that knows what it means to be part of the Franklin, PA community.”

While hiring a Franklin roofing contractor, it is important to choose the roofing company with confidence. Liberty Roofing Pro’s new guide, “Choosing the Right Franklin Roofing Company,” is here to help you avoid costly mistakes and find a roofer you can count on.

To check out the guide, visit Choosing the Right Franklin Roofing Company.

For more information or to schedule a free consultation, visit Liberty Roofing Pro’s official website at https://libertyroofingpros.com or directly contact via:

Email: office@libertyroofingpros.com

Phone: 844-478-7663

Google Reviews: https://g.page/LibertyRoofingPros?share

About Liberty Roofing Pro’s

Liberty Roofing Pro’s is a locally owned and operated roofing company serving Franklin, PA, and the surrounding areas. They specialize in roof repairs, roof replacements, and storm damage restoration, with a focus on honesty, transparency, and expert craftsmanship. Their commitment to customer satisfaction and quality roofing has made them one of the most trusted roofing contractors in the area. From small repairs to major replacements, Liberty Roofing Pro’s is ready to help homeowners protect one of their most important investments — their home.

For updates, follow Liberty Roofing Pro’s on Facebook: https://www.facebook.com/libertyroofingprosllc/

Media Contact
Company Name: Liberty Roofing Pro’s
Contact Person: Abner Miller
Email: Send Email
Phone: 844-478-7663
City: Franklin
State: Pennsylvania
Country: United States
Website: libertyroofingpros.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Liberty Roofing Pro’s Released “Choosing the Right Franklin Roofing Company,” – A Guide for Homeowners in Franklin, PA

Chronic Heart Failure Therapeutics Market Size in the 7MM was ~ USD 8,000 Million in 2023, is expected to grow by 2034 | DelveInsight

DelveInsight’s “Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of CHF, historical, and forecasted epidemiology as well as the CHF market trends in the US, EU4 (Germany, France, Italy, Spain), and the UK, and Japan.

Discover Key Insights into the Chronic Heart Failure Market with DelveInsight’s In-Depth Report @ Chronic Heart Failure Market Size

Key Takeaways from the Chronic Heart Failure Market Report

In December 2024:- AstraZeneca- A Phase IIb Two-Cohort, Randomised, Placebo-controlled, Double-blind, Multi-centre, Dose-ranging Study of AZD5462 in Stable Patients With Chronic Heart Failure. The main purpose of this study is to evaluate the effect of AZD5462 on cardiac function in participants with chronic heart failure (HF). This is a Phase IIb randomized, double-blind, placebo-controlled, multi-center, dose-ranging study to evaluate the efficacy, safety, and pharmacokinetic (PK) of AZD5462 on top of standard of care in 2 cohorts of participants with HF: Cohort A, and Cohort B.
In December 2024:- Regeneron Pharmaceuticals- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of a Single Dose of REGN5381, an NPR1 Monoclonal Antibody Agonist, in Patients With Chronic Heart Failure With Reduced Ejection Fraction. This study is researching an experimental drug called REGN5381 (called “study drug”). The study is focused on patients with heart failure with reduced ejection fraction (ie, the heart is not functioning as well as it should).
Driven by multiple factors, the number and distribution of reported cases of CHF have increased over time in the 7MM, among which the US contributed the major patient share.
As per DelveInsight’s estimate, the total diagnosed prevalent cases of CHF in the 7MM were approximately 20,360,000 in 2023.
In 2023, the percentage of diagnosed prevalence of males with heart failure in the US was 55%, and that for females was 45%.
In the UK, among all the four NYHA Classes of heart failure, Class II accounted for around 45% of the total diagnosed prevalent heart failure cases in 2023.
Among the EU4, the highest number of diagnosed prevalent cases of CHF were found in Germany, followed by France, and Spain, and the lowest number of diagnosed prevalent cases in Italy in 2023.
In Japan, the age-specific dignosed prevalent cases of heart failure in 2023 accounted for approximately 4,444,000 (for age group more than 60 years), 634,900 (for age group 40-59 years), and 211,600 (for age group below 39 years).
The leading Chronic Heart Failure Companies such as Novartis, Boehringer Ingelheim, Eli Lilly and Company, Bayer, Cytokinetics, BioCardia, Novo Nordisk, Mesoblast, and others.
Promising Chronic Heart Failure Therapies such as Ertugliflozin, Metolazone, AZD5462, Vericiguat (Verquvo, BAY1021189), mRNA-0184, rhNRG-1, and others.

Stay ahead in the Chronic Heart Failure Therapeutics Market with DelveInsight’s Strategic Report @ Chronic Heart Failure Market Outlook

Chronic Heart Failure Epidemiology Segmentation in the 7MM

Total Chronic Heart Failure Diagnosed Prevalent Cases
Chronic Heart Failure Gender-Specific Cases
Chronic Heart Failure Ejection fraction-specific cases
Chronic Heart Failure NYHA class-specific cases
Chronic Heart Failure Type-specific cases
Chronic Heart Failure Age-specific cases

Download the report to understand which factors are driving Chronic Heart Failure epidemiology trends @ Chronic Heart Failure Prevalence

Marketed Congestive Heart Failure Drugs

INJECTAFER (ferric carboxymaltose injection)/FERINJECT: American Regent, Vifor, and Daiichi Sankyo

INJECTAFER (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency in adult patients with heart failure; Iron Deficiency Anemia (IDA) in adult and pediatric patients 1-year of age and older who have either intolerance to oral iron or unsatisfactory response to oral iron; and adult patients with IDA who have non-dialysis dependent chronic kidney disease. Its dosing for iron deficiency in adult patients with heart failure and NYHA class II/III is based on patient weight and hemoglobin level starting at a single 500mg dose up to two 1000mg doses separated by six weeks.

INPEFA (sotagliflozin): Lexicon Pharmaceuticals and Viatris

INPEFA (sotagliflozin) is an oral inhibitor of two proteins responsible for glucose regulation known as SGLT2 and SGLT1. SGLT2 is responsible for glucose reabsorption by the kidney, and SGLT1 is responsible for glucose absorption in the gastrointestinal tract. In May 2023, Lexicon Pharmaceuticals announced that the US FDA had approved INPEFA (sotagliflozin) to reduce the risk of cardiovascular death, hHF, and uHF visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors. The broad label encompasses heart failure patients across the full range of LVEF, including HFpEF and HFrEF, and for patients with or without diabetes. The approval of INPEFA in heart failure indication, along with the breadth of the label, is a major milestone in Lexicon’s path to fulfilling its mission of pioneering medicines that transform patients’ lives.

Chronic Heart Failure Emerging Drugs

Omecamtiv mecarbil: Cytokinetics

Omecamtiv mecarbil is a selective small-molecule cardiac myosin activator. It is designed to directly target the contractile mechanism or pumping function of the heart. By stimulating cardiac myosin, a protein responsible for converting chemical energy into the mechanical force that helps the heart contract, omecamtiv mecarbil may improve cardiac muscle performance. Preclinical research has shown that cardiac myosin activators increase cardiac contractility without affecting intracellular myocyte calcium concentrations or myocardial oxygen consumption. It has completed its Phase III for CHF and its Phase III for HFrEF is anticipated in the fourth quarter of 2024.

KERENDIA (finerenone): Bayer

Finerenone is a nonsteroidal, selective Mineralocorticoid Receptor (MR) antagonist that has been shown to block the harmful effects of MR overactivation. MR overactivation contributes to Chronic Kidney Disease (CKD) progression and cardiovascular damage, which can be driven by metabolic, hemodynamic, or inflammatory and fibrotic factors. Finerenone is marketed as KERENDIA or, in some countries, as FIRIALTA, and approved for the treatment of adult patients associated with Type II Diabetes (T2D) in more than 90 countries worldwide, including in China, Europe, Japan, and the US. It has completed its Phase III trial for heart and left ventricular ejection fraction =40% and the company is anticipating the first submission of the drug by mid-2025.

Get In-Depth Knowledge on Chronic Heart Failure Market Trends and Forecasts with DelveInsight @ Chronic Heart Failure Treatment Market

Chronic Heart Failure Companies

Novartis, Boehringer Ingelheim, Eli Lilly and Company, Bayer, Cytokinetics, BioCardia, Novo Nordisk, Mesoblast, and others

Chronic Heart Failure Market Outlook

After a scarcity of sustainable new therapies for more than a decade, new classes of agents for the treatment of patients with CHF were approved by the US FDA – VERQUVO (vericiguat), ENTRESTO (sacubitril/valsartan), a combined Angiotensin Receptor-neprilysin Inhibitor (ARNI) and CORLANOR (ivabradine), a sinoatrial node modulator. Both drugs are recommended for use as part of a comprehensive medical therapy regimen. Recently approved INJECTAFER (ferric carboxymaltose injection)/FERINJECT by American Regent, Vifor, and Daiichi Sankyo and INPEFA (sotagliflozin) by Lexicon Pharmaceuticals and Viatris, in 2023 are the newest additions for treating heart failure. These drugs are indicated for the treatment of iron deficiency in adult patients with heart failure and to reduce the risk of cardiovascular death, hHF, and uHF visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors, respectively. VERQUVO is a stimulator of soluble guanylate cyclase.

Chronic Heart Failure Drugs Market

Currently, heart failure treatment depends on angiotensin-converting enzyme inhibitors, angiotensin receptor II blockers, beta-blockers, and diuretics. Other therapies, such as aldosterone antagonists, amiodarone, antiaggregants, anticoagulants, calcium antagonists, diuretics, and nitrates, are used to treat patients affected by heart failure. The majority of therapies are prescribed in combination, and beta-blockers are one of the most prescribed classes. Among the approved therapies, ENTRESTO is Novartis’ one of the most important drugs, and its revenue is expected to rise in the next years. At present, ENTRESTO leads the CHF market among the approved therapies.

Unlock Strategic Insights with DelveInsight’s Comprehensive Chronic Heart Failure Market Report @ Chronic Heart Failure Market Drivers and Barriers

Scope of the Chronic Heart Failure Market Report

Coverage- 7MM
Study Period- 2020-2034
Chronic Heart Failure Companies- Novartis, Boehringer Ingelheim, Eli Lilly and Company, Bayer, Cytokinetics, BioCardia, Novo Nordisk, Mesoblast, and others.
Chronic Heart Failure Therapies- Ertugliflozin, Metolazone, AZD5462, Vericiguat (Verquvo, BAY1021189), mRNA-0184, rhNRG-1, and others.
Chronic Heart Failure Market Dynamics: Chronic Heart Failure Market Drivers and Barriers
Chronic Heart Failure Unmet Needs, KOL’s views, Analyst’s views, Chronic Heart Failure Market Access and Reimbursement

Table of Content

1. Key Insights

2. Chronic Heart Failure Report Introduction

3. Chronic Heart Failure Executive Summary

4. Chronic Heart Failure Market Overview at a Glance

5. Chronic Heart Failure Key Events

6. Chronic Heart Failure Epidemiology and Market Forecast Methodology

7. Chronic Heart Failure Disease Background and Overview

9. Chronic Heart Failure Epidemiology and Patient Population

10. Patient Journey

11. Chronic Heart Failure Marketed Drugs

12. Chronic Heart Failure Emerging Drugs

13. Chronic Heart Failure: 7MM Analysis

14. Chronic Heart Failure Unmet needs

15. Chronic Heart Failure SWOT Analysis

16. Chronic Heart Failure KOL Views

17. Chronic Heart Failure Market Access and Reimbursement

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Heart Failure Therapeutics Market Size in the 7MM was ~ USD 8,000 Million in 2023, is expected to grow by 2034 | DelveInsight

Joseph Grinkorn: The Trump Bull Market is Here – Markets Set to Hit New Highs by 2025

According to Morris Group CEO Joseph Grinkorn, Trump’s return and aggressive economic policies are already shaping a strong future for Wall Street, with significant growth expected.

December 10, 2024 – In an insightful forecast, Joseph Grinkorn, CEO of Morris Group, asserts that the financial markets are primed for unprecedented growth following Donald Trump’s return as the 47th President of the United States. Grinkorn believes that implementing Trump’s aggressive economic policies is already setting the stage for a historic bull market, with expectations for Wall Street to reach all-new highs by 2025.

“Trump’s approach is unlocking new market highs by prioritizing key economic reforms,” Grinkorn states. He points to Trump’s focused agenda, which includes energy independence, trade reform, and tackling inflation, as crucial drivers for economic resurgence and financial resilience.

Energy Independence: Lowering Costs and Boosting Nuclear Power

Grinkorn highlights Trump’s renewed commitment to energy policies to reduce costs and increase domestic production through nuclear power development, eliminating the nation’s reliance on foreign oil. This strategic emphasis advocates for lower energy expenses foster industrial growth and enhances consumer spending.

Trade and Tariffs: Protecting U.S. Jobs and Reducing Debt

The Trump administration’s stance on tariffs is designed to safeguard American jobs and contribute to national debt reduction. Grinkorn explains, “Trump’s tariffs protect American jobs and reduce national debt, fostering a more robust economy and increased stability.” By reducing dependencies on imports, particularly in manufacturing sectors, Trump’s policies align with Grinkorn’s vision of long-term economic growth and job creation.

Tackling Inflation: Lowering Prices to Boost Consumer Confidence

Addressing inflation has also been a priority for Trump, with initiatives to lower consumer prices. Grinkorn emphasizes how Trump’s efforts to “End inflation and make America affordable again” revitalize consumer purchasing power, particularly concerning essentials like food and energy.

Immigration and National Security: Enhancing Public Safety

Trump’s proposals on immigration, which include the completion of the border wall and stricter enforcement measures, play a significant role in his broader economic agenda. Grinkorn notes that these policies aim to enhance public safety and indirectly foster economic growth by bolstering investor confidence through improved national stability.

As the market landscape shifts, Grinkorn remains optimistic about the future. “With Trump’s policies taking root, the U.S. economy is experiencing unparalleled growth. Investors should stay informed and be prepared for these exciting changes ahead,” he added.

For more information, please visit www.Morris-Group.co

About Morris Group

Founded by Joseph Grinkorn in 2007, Morris Group specializes in high-return real estate investments, commercial and residential financing, and strategic equity placements in technology and alternative assets. By leveraging comprehensive market insights, Morris Group has established a reputation as a trusted leader in the investment sector.

Media Contact
Company Name: Morris Group
Contact Person: Joseph Grinkorn
Email: Send Email
Phone: (646) 673-8404
Country: United States
Website: www.Morris-Group.co

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Joseph Grinkorn: The Trump Bull Market is Here – Markets Set to Hit New Highs by 2025

Spring Hill School District Announces Marc Williams as Executive Director of Operations

“Image: Marc Williams, Executive Director of Operations, effective July 1, 2025”

Marc Williams, principal of Spring Hill High School for the past decade, has been named the district’s first Executive Director of Operations. Williams will oversee key departments and continue his dedication to advancing the district’s mission while fostering collaboration and operational excellence.

SPRING HILL, Kan. – December 10, 2024 – The Spring Hill School District is pleased to announce that Marc Williams, current Spring Hill High School principal, has been named the district’s inaugural Executive Director of Operations. Effective July 1, 2025, this newly created position will oversee critical departments, including Technology, Facilities, Nutrition Services, and Communications, and will serve as a liaison to community organizations and law enforcement to support the district’s growth and operational excellence.

Williams, who has been the principal of Spring Hill High School for the past decade, expressed bittersweet feelings about transitioning from the day-to-day engagement with students, staff, and parents.

“Spring Hill High School is a special place,” said Williams regarding his time leading staff and students at the high school. “I have been very fortunate to be the principal for the last 10 years. I will miss my daily interactions with staff, students, and parents, but I am extremely fortunate that I will continue to work in Spring Hill.”

Williams’ passion for the district is evident. “This district truly cares about students and getting them prepared for post-graduation. I have also admired the way the district and community have worked together to handle the rapid growth we have experienced, all while focusing on providing our students with the best education possible.”

Williams believes his 19 years as a high school principal have prepared him for the new role by fostering strong relationships with staff and community members. “I don’t know if any one thing has prepared me for this new role. Being a high school principal for 19 years, I have learned the importance of creating working relationships with community members and staff. I have great working relationships with others in the district and will continue to work together to enhance Spring Hill USD 230.”

This new role also aligns with his career aspirations. “It provides me the opportunity to work in the district office and see the district as a whole and not just through the lens of Spring Hill High School. As one who desired to advance in their career, this provides me an opportunity to learn from some outstanding individuals while continuing to work for USD 230,” Williams added.

The Executive Director of Operations position is central to the district’s strategic goals, as outlined by Dr. Link Luttrell, Superintendent of Schools. “Marc’s wealth of experience and dedication to Spring Hill Schools make him the ideal candidate for this pivotal new role. His leadership will be instrumental as we continue to grow and enhance our operational systems to best serve our students and community,” Luttrell said.

Dr. Joshua Robinson, Assistant Superintendent of Schools, echoed this sentiment. “This role requires a leader who understands the complexities of school operations and the importance of collaboration across departments. Marc’s track record of excellence and his passion for education will make a significant impact in this position.”

Williams officially begins his new role on July 1, 2025. A search for a new principal for Spring Hill High School will commence immediately to ensure a smooth transition.

About Spring Hill Schools

Spring Hill Schools is dedicated to fostering a culture of innovation, collaboration, and excellence in education. Serving more than 4,000 students across ten schools, the district prioritizes preparing learners for a bright and prosperous future.

Media Contact
Company Name: Spring Hills (USD 230)
Contact Person: Stephanie Neiger
Email: Send Email
Phone: 913-592-7258
City: Spring Hill
State: Kansas
Country: United States
Website: www.usd230.org

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Spring Hill School District Announces Marc Williams as Executive Director of Operations

Spring Hill Schools Promotes Dr. Erin Smith to Newly Created Role of Executive Director of Schools and Services

“Image: Erin Smith, Ed.D., Director of Schools and Services, effective July 1, 2025”

Spring Hill Schools proudly announces the promotion of (Dr.) Erin Smith, Ed.D., to the newly created position of Executive Director of Schools and Services, where she will oversee key departments and initiatives to enhance student success and operational excellence.

SPRING HILL, Kan. – December 10, 2024 – Spring Hill Schools is proud to announce the promotion of Dr. Erin Smith to the newly created position of executive director of schools and services. Dr. Smith, who has served as the district’s director of teaching and learning, will transition to her new role effective July 1, 2025. This strategic position reflects the district’s commitment to academic excellence, innovation, and leadership, ensuring all students and staff are supported in achieving their full potential.

In her new role, Dr. Smith will oversee the district’s special services, human resources, and teaching and learning departments. She will lead key initiatives, including the district’s accreditation process, the student transfer program, administrative retreats, and aligning strategic goals with community priorities. Her leadership will directly impact instructional quality, professional development, and operational excellence throughout the district.

“This new position is an exciting opportunity to expand my contributions to Spring Hill Schools,” Dr. Smith said. “My experience with district-wide initiatives like curriculum development, accreditation, and strategic planning has prepared me to take on these responsibilities. I’m eager to support our principals and staff in enhancing learning opportunities for every student while fostering a culture of collaboration and innovation.”

Dr. Smith also expressed her passion for the district and its people. “Spring Hill Schools is special because of its innovative spirit and strong community values,” she said. “I’m deeply committed to continuing our tradition of excellence by building programs that meet the needs of all students and preparing them for a bright future.”

District leaders echoed Dr. Smith’s enthusiasm for her new role.

“Dr. Smith’s deep understanding of our district’s needs and her proven leadership make her uniquely qualified to take on this important role,” said Dr. Joshua Robinson, Assistant Superintendent of Schools.

“This new position is pivotal in addressing the complex demands of our growing district,” added Dr. Link Luttrell, Superintendent of Schools, “Dr. Smith’s leadership, vision, and dedication ensure that we can continue to deliver outstanding education and support for our students and staff.”

Dr. Smith’s extensive experience includes leading the Kansas Education Systems Accreditation (KESA) process, developing and implementing district-wide curricula, facilitating professional development programs, and managing strategic planning initiatives. Her expertise in fiscal management, data analysis, and instructional design positions her to effectively guide schools and student services in this expanded role.

Spring Hill Schools created the executive director of schools and services role to better align district operations with its mission of fostering innovation and academic achievement. By combining oversight of multiple departments and direct support for school leadership, this position ensures a streamlined approach to advancing student outcomes.

About Spring Hill Schools

Spring Hill Schools is dedicated to fostering a culture of innovation, collaboration, and excellence in education. Serving more than 4,000 students across 10 schools, the district prioritizes preparing learners for a bright and prosperous future.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Spring Hill Schools Promotes Dr. Erin Smith to Newly Created Role of Executive Director of Schools and Services

Fetal Monitoring Market Growing Size, Share, Revenue Growth, Top Key Companies, Industry Analysis, Advance Technology, Future Development & Forecast

“The major players operating in this market are Cardinal Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), FUJIFILM SonoSite, Inc. (US), Natus Medical Incorporated (US)”

Browse 221 market data Tables and 45 Figures spread through 246 Pages and in-depth TOC on “Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User, Region – Global Forecast to 2027

Fetal Monitoring Market size is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, at a CAGR of 7.3% according to a new report by MarketsandMarkets™. The reimbursement for fetal monitoring, insurance policies for fetal monitoring services, and the more number of obstetrics and gynaecology centres are the major factors driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35700261

The ultrasound devices segment accounted for the largest share of the fetal monitoring market, by product segment, in 2021

The fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products based on products. In 2021 ultrasound devices segment accounted for the larger share in the market. This segment’s growth can primarily be attributed to the rising number of diagnostic clinics and maternity centers.

Non-portable systems segment to register the highest growth rate during the forecast period

Based on portability, the market is segmented into non-portable systems and portable systems. In 2021, non-portable systems accounted for the largest share of this market, owing to wide applications in hospitals and diagnostic centers to assess fetal and maternal health.

Non-invasive method segment accounted for the largest share of the fetal monitoring, by method segment, in 2021

Based on the method, the market is segmented into invasive and non-invasive. In 2021, the non-invasive accounted for the largest share of this market. Non-invasive methods are widely accepted for their safer method of diagnosing and monitoring the fetus, especially in high-risk pregnancies and rising advanced technologies drive the growth of this segment.

Antepartum segment accounted for the largest share of the fetal monitoring, by application segment, in 2021

The market is segmented into antepartum and intrapartum based on application. The antepartum segment accounts for the largest share of the fetal monitoring market. The diagnosis of any congenital fetal abnormalities, antepartum fetal monitoring is carried out during the gestation period. The increasing incidence of fetal anomalies drive the growth of the antepartum segment.

Home care settings to register the highest growth rate during the forecast period

Based on end users the market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings. In 2021, hospitals accounted for the largest share of this market. This growth of this segment can be attributed to the growing number of pregnancy procedures, and availability of highly advanced facilities in hospitals.

North America is the largest regional market for fetal monitoring market

The global fetal monitoring market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America was the largest regional market for fetal monitoring. The rising number of premature births in the region are the major factors supporting the growth of the fetal monitoring market in North America. However, the Asia Pacific region offers high-growth opportunities for players in the fetal monitoring market. This regional segment is projected to register the highest CAGR during the forecast period. Factors such as rising birth rates, and healthcare infrastructure improvements in several Asia Pacific countries are factors driving the market growth in the region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=35700261

Fetal Monitoring Market Dynamics:

Drivers:

Rising number of preterm births and increasing adoption of infertility treatment
Advanced and innovative fetal monitoring technologies
Government initiatives and increasing collaborations for research by health agencies
Reimbursement and insurance policies for fetal monitoring services
Active product launches by key manufacturers
Increasing number of obstetrics and gynecology centers for fetal monitoring

Restraints:

High costs of fetal monitoring equipment
Availability of refurbished products

Opportunities:

Development of non-invasive, portable, and advanced fetal monitors
Emerging markets and strengthening infrastructure

Challenges:

Product recalls
Lack of skilled healthcare professionals

Key Market Players:

The major players operating in this market are Cardinal Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), FUJIFILM SonoSite, Inc. (US), Natus Medical Incorporated (US), Huntleigh Healthcare Limited (UK), The Cooper Companies Inc. (US), CONTEC Medical Systems Co., Ltd. (China), EDAN Instruments, Inc. (China), Neoventa Medical AB (Sweden), Bionet Co., Ltd. (South Korea), Progetti Srl (Italy), TRISMED Co., Ltd. (Republic of Korea), ShenZhen Luckcome Technology Inc. (China), MedGyn Products, Inc (US), Dixion (Germany), Promed Group Co., Ltd. (Hong Kong), Advanced Instrumentations (US), BRAEL-Medical Equipment (Poland), GPC Medical (India), BISTOS (Korea), Mediana Co. Ltd (Korea), Life Plus Medical (India), ChoiceMMed (China), Trivitron Healthcare (India), Dott Medical Co. Ltd. (China), Shenzhen Comen Medical Instruments Co., Ltd. (China), Shenzhen Vcomin Technology Limited (China), Nemo Healthcare (Netherlands), MindChild Medical, Inc. (US), Melody International Ltd. (Japan), Janitri Innovations Pvt. Ltd. (India), and Laerdal Global Health (Norway).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=35700261

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Fetal Monitoring Market Growing Size, Share, Revenue Growth, Top Key Companies, Industry Analysis, Advance Technology, Future Development & Forecast